ANNA BAYES: Open Payments
NPI 1548379175 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 84 payments from 19 companies in 2025. Trend: 2023 $1,069 · 2024 $1,613 · 2025 $1,863
Food & beverage: $1,863
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $353 |
| GENZYME CORPORATION | 10 | $317 |
| Verona Pharma, Inc. | 11 | $216 |
| AstraZeneca Pharmaceuticals LP | 5 | $206 |
| Grifols USA, LLC | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Baxter Healthcare | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Inspire Medical Systems, Inc. | 3 | $65 |
| Insmed, Inc. | 2 | $51 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, AIRSUPRA, TRELEGY ELLIPTA, Prolastin-C Liquid, Hillrom - Vest System Model 105 Home Care, CAPLYTA.
Industry payments across KY — which companies pay providers there.
